Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BNTX
DXCM
Add up to 3 more stocks
BNTX
BioNTech SE
+5.12%
$116.57+5.68At close: Aug 21, 2026, 4:00 PM ET
Market Cap
$29.28B
52W Range
$79.52 - $124.00
DXCM
DexCom, Inc.
+2.35%
$92.34+2.12At close: Aug 21, 2026, 4:00 PM ET
Market Cap
$34.85B
52W Range
$54.11 - $92.56
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 36.50 |
| Forward P/E | N/A | 34.61 |
| P/B Ratio | 1.46 | 13.80 |
| P/S Ratio | 9.53 | 7.28 |
| P/FCF Ratio | 47.73 | 25.75 |
| EV/EBITDA | N/A | 25.99 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.0% | 62.5% |
| Operating Margin | -22.6% | 22.9% |
| Net Margin | -63.0% | 20.1% |
| ROE | -9.6% | 38.1% |
| ROA | -8.4% | 15.5% |
| ROIC | -10.4% | 21.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 7.85 | 1.73 |
| Quick Ratio | 7.80 | 1.43 |
| Debt/Equity | 0.02 | 0.53 |
| Interest Coverage | -45.74 | 49.83 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.